Catalio Capital Management, LP, a multi-strategy life sciences investment firm with more than $1bn in AuM, has launched a dedicated public equities hedge fund investment strategy focused on identifying compelling life science investment opportunities globally.

Life science is the study of living organisms and life processes. Biology, medicine, agri